Drug General Information
Drug ID
D0G9XP
Former ID
DCL001205
Drug Name
LB80380
Drug Type
Small molecular drug
Indication HBV infection [ICD9: 070.2-070.3; ICD10:B16, B18.0, B18.1] Phase 2b [551083]
Company
LG Life Sciences
Structure
Download
2D MOL

3D MOL

Formula
C22H34N5O8P
Canonical SMILES
CC(C)(C)C(=O)OCOP(=O)(COC1(CC1)CN2C=NC3=CN=C(N=C32)N)OC<br />OC(=O)C(C)(C)C
InChI
1S/C22H34N5O8P/c1-20(2,3)17(28)31-12-34-36(30,35-13-32-18(29)21(4,5)6)14-33-22(7-8-22)10-27-11-25-15-9-24-19(23)26-16(15)27/h9,11H,7-8,10,12-14H2,1-6H3,(H2,23,24,26)
InChIKey
JLKJXDOWBVVABZ-UHFFFAOYSA-N
PubChem Compound ID
PubChem Substance ID
Target and Pathway
Target(s) DNA polymerase/reverse transcriptase Target Info Inhibitor [551083]
References
Ref 5510832011 Pipeline of LG Life Sciences.
Ref 5510832011 Pipeline of LG Life Sciences.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.